Evidence map›Paper›PMID 24852375›Full record

ArticleHuman molecular genetics2014

A comprehensive examination of breast cancer risk loci in African American women.

Ye Feng, Daniel O Stram, Suhn Kyong Rhie, Robert C Millikan, Christine B Ambrosone, Esther M John, Leslie Bernstein, Wei Zheng, Andrew F Olshan, Jennifer J Hu and 23 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Pooled it
  5. Putative linkage signals identified for breast cancer in African American families.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Breast cancer in sub-Saharan Africa: The current state and uncertain future.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  11. Article
  12. Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 19 institutions in 3 countries.

Ye FengDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Daniel O StramDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Suhn Kyong RhieDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Robert C MillikanDepartment of Epidemiology, Gillings School of Global Public Health, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Christine B AmbrosoneDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Esther M JohnCancer Prevention Institute of California, Fremont, CA, USA Division of Epidemiology, Department of Health Research & Policy, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Leslie BernsteinDivision of Cancer Etiology, Department of Population Science, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Andrew F OlshanDepartment of Epidemiology, Gillings School of Global Public Health, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Jennifer J HuSylvester Comprehensive Cancer Center and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL, USA.
Regina G ZieglerEpidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics and.
Sarah NyanteDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Elisa V BanderaRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Sue A InglesDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Michael F PressDepartment of Pathology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Sandra L DemingDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jorge L Rodriguez-GilSylvester Comprehensive Cancer Center and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL, USA.
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, MA, USA.
Olufunmilayo I OlopadeCenter for Clinical Cancer Genetics & Global Health, Department of Medicine and.
Dezheng HuoDepartment of Health Studies, University of Chicago, Chicago, IL, USA.
Clement A AdebamowoDepartment of Epidemiology & Preventive Medicine, University of Maryland, Baltimore, MD, USA.
Temidayo OgundiranDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Gary K ChenDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Alex StramDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Karen ParkDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Kristin A RandDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Stephen J ChanockEpidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics and.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Laurence N KolonelEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
David V ContiDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Douglas EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Brian E HendersonDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and haiman@usc.edu.
USC Norris Comprehensive Cancer Center · USCancer Genetics (United States) · USDivision of Cancer Epidemiology and GeneticsUniversity of Miami · USVanderbilt University · USBoston University · USCancer Prevention Institute of California · USCity of Hope · USRoswell Park Comprehensive Cancer Center · USRutgers Cancer Institute of New JerseyUNC Lineberger Comprehensive Cancer CenterUniversity of Cambridge · GBUniversity of Chicago · USUniversity of Hawaiʻi at Mānoa · USUniversity of Hawaii System · USUniversity of Ibadan · NGUniversity of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · US

Funding

Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
FOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7M
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7M
Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI COX, NANCY · 2006 to 2010
$11.3M
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort StudyUM1CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HENDERSON, BRIAN E, LE MARCHAND, LOIC · 2012 to 2014
$11.3M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
Cancer Research UK 16563Cancer Research UK C12292/A11174Cancer Research UK C1281/A12014Cancer Research UK C1287/A10118Cancer Research UK C1287/A10710Cancer Research UK C5047/A10692Cancer Research UK C5047/A15007Cancer Research UK C5047/A8384CIHRNCI NIH HHS 1U19 CA148065NCI NIH HHS 1U19 CA148112NCI NIH HHS 1U19 CA148537NCI NIH HHS CA128978NCI NIH HHS K05 CA136967NCI NIH HHS P50 CA058223NCI NIH HHS P50 CA125183NCI NIH HHS P50-CA125183NCI NIH HHS P50-CA58223NCI NIH HHS R01 CA058420NCI NIH HHS R01-CA058420NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA073629NCI NIH HHS R01 CA089085NCI NIH HHS R01 CA098663NCI NIH HHS R01-CA098663NCI NIH HHS R01 CA100374NCI NIH HHS R01-CA100374NCI NIH HHS R01 CA100598NCI NIH HHS R01-CA100598NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA141712NCI NIH HHS R01-CA141712NCI NIH HHS R01 CA142996NCI NIH HHS R01-CA63464NCI NIH HHS R01-CA73629NCI NIH HHS R01-CA77305NCI NIH HHS R01 CA89085NCI NIH HHS R37 CA054281NCI NIH HHS R37-CA54281NCI NIH HHS U01 CA182898NCI NIH HHS U19 CA148065NCI NIH HHS U19-CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS UM1 CA164920NCI NIH HHS UM1 CA164973NCI NIH HHS UM1-CA164973NICHD NIH HHS N01-HD-3-3175NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P30-ES10126
6 · The paper itself

Abstract

Genome-wide association studies have identified 73 breast cancer risk variants mainly in European populations. Given considerable differences in linkage disequilibrium structure between populations of European and African ancestry, the known risk variants may not be informative for risk in African ancestry populations. In a previous fine-mapping investigation of 19 breast cancer loci, we were able to identify SNPs in four regions that better captured risk associations in African American women. In this study of breast cancer in African American women (3016 cases, 2745 controls), we tested an additional 54 novel breast cancer risk variants. Thirty-eight variants (70%) were found to have an association with breast cancer in the same direction as previously reported, with eight (15%) replicating at P < 0.05. Through fine-mapping, in three regions (1q32, 3p24, 10q25), we identified variants that better captured associations with overall breast cancer or estrogen receptor positive disease. We also observed suggestive associations with variants (at P < 5 × 10(-6)) in three separate regions (6q25, 14q13, 22q12) that may represent novel risk variants. Directional consistency of association observed for ∼65-70% of currently known genetic variants for breast cancer in women of African ancestry implies a shared functional common variant at most loci. To validate and enhance the spectrum of alleles that define associations at the known breast cancer risk loci, as well as genome-wide, will require even larger collaborative efforts in women of African ancestry.

Indexed as

Genetic Predisposition to DiseaseBlack or African AmericanBreast NeoplasmsFemaleGenetic LociGenetic VariationGenome-Wide Association StudyHumansPolymorphism, Single NucleotideReceptors, EstrogenReceptors, Estrogen

Identifiers

PMID24852375
PMCPMC4168823
OpenAlexW2132894015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.